Full Press Release Details
Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Colleen Dekker (317) 989-7011 colleen.dekker@elancoah.com
Elanco Appoints Robert (Bob) VanHimbergen as
Chief Financial Officer
GREENFIELD, Ind. (May 28, 2025) Elanco Animal Health
Incorporated (NYSE: ELAN) today announced the appointment of Robert VanHimbergen as Executive Vice President and Chief Financial Officer,
effective July 7, 2025. VanHimbergen's appointment follows an extensive and competitive search as part of the company's commitment
to long-term, sustained value creation. VanHimbergen succeeds Todd Young, who will remain with the company as an advisor through August
31, 2025, to facilitate a smooth transition.
VanHimbergen currently serves as the Senior Vice President
and Chief Financial Officer of Hillenbrand, Inc., where he contributed to the company's transformation into a pure-play industrial
company. Prior to joining Hillenbrand, he spent 15 years at Johnson Controls where he led the global finance, accounting and reporting
functions, was a member of the executive leadership team and was deeply involved in Johnson Controls' enterprise transformation initiative.
He previously held roles within Johnson Controls, including CFO of the $9 billion automotive interiors business in Shanghai, China, and
led the battery division in Asia. Prior to Johnson Controls, VanHimbergen spent nearly a decade at PricewaterhouseCoopers LLP working
with large multi-national companies.
"We are excited for Bob to join the Elanco Executive
Committee to help guide the continuation of our increasing value creation. With seven consecutive quarters of growth and a portfolio of
potential blockbusters in launch mode, Elanco is focused on accelerating growth, globalizing and maximizing existing innovation, supporting
the next wave of innovation, expanding margins, and improving cash generation," said Jeff Simmons, Elanco President and CEO. "Bob's
nearly three decades of experience leading finance organizations, along with his leadership style focused on value creation will be extremely
beneficial to build on our current momentum as we maximize the opportunity in front of us."
"I am thrilled to join Elanco at this exciting time
with the company's momentum and diverse portfolio of innovation," commented VanHimbergen. "I look forward to working
with the leadership team to execute on the company's strategy, accelerate growth and enhance shareholder value."
Simmons continued, "On behalf of the entire Elanco
organization, we are grateful for Todd's contributions as we stood up Elanco as an independent company, completed acquisitions to
diversify our portfolio, increased our global scale, delivered innovation, enhanced capabilities and took important steps to pay down
debt. I express my appreciation to Todd for his more than six years of leadership with the Elanco team and enhancing animal health. I
greatly value everything Todd has done to put Elanco in a position of strength. This is the right time for a proactive change."
"It has been my privilege to work alongside such a
dedicated Elanco team to position the company for its next stage of growth," said Todd Young. "Elanco is well positioned to
execute its strategy, and I look forward to supporting this transition."
The company also reconfirms the second quarter and full
year guidance issued on the first quarter earnings call on May 7, 2025.
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader
in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets,
creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage,
we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also
making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching
Life and our Elanco Healthy Purpose sustainability pillars - all to advance the health of animals, people, the planet and
our enterprise. Learn more at www.elanco.com.
Cautionary Statement Regarding Forward-Looking Statements
The reconfirmation of guidance contained in this press release involves
forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are based on our current expectations
and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future,
by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. As a result,
our actual results may differ materially from those contemplated by the forward-looking statements. Important risk factors that could
cause actual results to differ materially from those in the forward-looking statements include regional, national or global political,
economic, business, competitive, market and regulatory conditions, including but not limited to the following:
For additional information about the factors that could cause actual
results to differ materially from forward-looking statements, please see the company's latest Form 10-K and Form 10-Qs filed with
the Securities and Exchange Commission. Although we have attempted to identify important risk factors, there may be other risk factors
not presently known to us or that we presently believe are not material that could cause actual results and developments to differ materially
from those made in or suggested by the forward-looking statements contained in this press release. If any of these risks materialize,
or if any of the above assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially
from those made in or suggested by the forward-looking statements contained in this press release. We caution you against relying on any
forward-looking statements, which should also be read in conjunction with the other cautionary statements that are included elsewhere
in this press release. Any forward-looking statement made by us in this press release speaks only as of the date thereof. Factors or events
that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake
no obligation to publicly update or to revise any forward-looking statement, whether as a result of new information, future developments
or otherwise, except as may be required by law. Comparisons of results for current and any prior periods are not intended to express any
future trends or indications of future performance, unless specifically expressed as such, and should be viewed as historical data.